Parallax Volatility Advisers, L.P. - ARROWHEAD PHARMACEUTICALS IN ownership

ARROWHEAD PHARMACEUTICALS IN's ticker is ARWR and the CUSIP is 04280A100. A total of 315 filers reported holding ARROWHEAD PHARMACEUTICALS IN in Q4 2020. The put-call ratio across all filers is 0.54 and the average weighting 0.4%.

Quarter-by-quarter ownership
Parallax Volatility Advisers, L.P. ownership history of ARROWHEAD PHARMACEUTICALS IN
ValueSharesWeighting
Q3 2020$1,458,000
+515.2%
33,857
+303.3%
0.00%
Q3 2019$237,000
-92.8%
8,396
-93.3%
0.00%
-100.0%
Q2 2019$3,313,000
+308.5%
125,000
+183.0%
0.00%
+300.0%
Q1 2019$811,000
+4.6%
44,163
-29.2%
0.00%0.0%
Q4 2018$775,000
-49.5%
62,361
-22.0%
0.00%
-50.0%
Q3 2018$1,534,000
+11700.0%
80,000
+8105.1%
0.00%
Q2 2018$13,0009750.00%
Other shareholders
ARROWHEAD PHARMACEUTICALS IN shareholders Q4 2020
NameSharesValueWeighting ↓
WESTERN FINANCIAL Corp 820,346$62,945,00041.38%
Johnson & Johnson Innovation - JJDC, Inc. 3,260,869$250,206,00032.27%
Aquilo Capital Management, LLC 365,926$28,078,0005.84%
L1 Capital Pty Ltd 298,687$23,127,0004.32%
First Light Asset Management, LLC 704,449$54,052,0004.00%
ACUTA CAPITAL PARTNERS, LLC 139,000$10,665,0002.90%
Evolutionary Tree Capital Management, LLC 48,265$3,703,0002.82%
Parkman Healthcare Partners LLC 127,171$9,758,0002.50%
Capital Impact Advisors, LLC 88,183$6,766,0001.66%
Tri Locum Partners LP 56,003$4,297,0001.56%
View complete list of ARROWHEAD PHARMACEUTICALS IN shareholders